Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Siegrist

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitroHulda R Jonsdottir, Denise Siegrist, Thomas Julien, et al.
Analytical Chemistry|December 2, 2021
Rapid Identification of SARS-CoV-2 Variants of Concern Using a Portable <i>peak</i>PCR PlatformPhilippe Bechtold, Philipp Wagner, Salome Hosch, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitroHulda R Jonsdottir, Denise Siegrist, Thomas Julien, et al.
Analytical Chemistry|December 2, 2021
Rapid Identification of SARS-CoV-2 Variants of Concern Using a Portable <i>peak</i>PCR PlatformPhilippe Bechtold, Philipp Wagner, Salome Hosch, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Pageof 2